Moneycontrol

Moneycontrol PRO

you are here: HomeNewsBusinessStocksPharma pricing policy to hurt Cipla, Ranbaxy, Lupin: Vijay

SHOW NAMES

Trending Topics

business

Pharma pricing policy to hurt Cipla, Ranbaxy, Lupin: Vijay

PN Vijay, Portfolio Manager, askpnvijay.com, says that companies like Cipla and Ranbaxy would be largely affected by the pricing policy because they have large presence in domestic life saving drugs space and to some extent affect will be seen on Lupin.

first published: Nov 23, 2012 10:34 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347